VVT Med Inc. (TSXV:VVTM)
0.2700
0.00 (0.00%)
At close: Feb 9, 2026
VVT Med Company Description
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins.
It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P – 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider veins.
The company was founded in 2004 and is based in Kfar Saba, Israel.
VVT Med Inc.
| Country | Canada |
| Founded | 2004 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Erez Tetro |
Contact Details
Address: Hasadna 6 st. Kfar Saba, 4442405 Israel | |
| Phone | 972 9 766 0480 |
| Website | vvtmed.com |
Stock Details
| Ticker Symbol | VVTM |
| Exchange | TSX Venture Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erez Tetro | Chief Executive Officer and Director |
| Dor Sneh | Chief Financial Officer and Corporate Secretary |
| Gideon Vitkon | Chief of Operations |
| Orly Efrati | Vice President of Global Marketing |